These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1370084)

  • 1. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
    Matsuda M; Reichman CT; Hanafusa H
    J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
    Matsuda M; Mayer BJ; Hanafusa H
    Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
    Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
    J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.
    Matsuda M; Mayer BJ; Fukui Y; Hanafusa H
    Science; 1990 Jun; 248(4962):1537-9. PubMed ID: 1694307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner.
    Cleghon V; Morrison DK
    J Biol Chem; 1994 Jul; 269(26):17749-55. PubMed ID: 7517401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.
    Mayer BJ; Hanafusa H
    J Virol; 1990 Aug; 64(8):3581-9. PubMed ID: 1695251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
    Sabe H; Okada M; Nakagawa H; Hanafusa H
    Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
    Reichman CT; Mayer BJ; Keshav S; Hanafusa H
    Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
    Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
    Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.
    Hirai H; Varmus HE
    Mol Cell Biol; 1990 Apr; 10(4):1307-18. PubMed ID: 2108315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.
    Sakai R; Iwamatsu A; Hirano N; Ogawa S; Tanaka T; Mano H; Yazaki Y; Hirai H
    EMBO J; 1994 Aug; 13(16):3748-56. PubMed ID: 8070403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible v-Crk-induced transformation through activation of Src kinases.
    Sabe H; Shoelson SE; Hanafusa H
    J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple SH2-mediated interactions in v-src-transformed cells.
    Koch CA; Moran MF; Anderson D; Liu XQ; Mbamalu G; Pawson T
    Mol Cell Biol; 1992 Mar; 12(3):1366-74. PubMed ID: 1545818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.
    Mayer BJ; Hanafusa H
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2638-42. PubMed ID: 1690891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
    Fajardo JE; Birge RB; Hanafusa H
    Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate.
    Flynn DC; Leu TH; Reynolds AB; Parsons JT
    Mol Cell Biol; 1993 Dec; 13(12):7892-900. PubMed ID: 8247004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
    Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
    Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.